HUP0000737A2 - Hialuronsav mikrorészecskékbe foglalt hatóanyagokat tartalmazó nyújtott hatóanyagleadású készítmény - Google Patents

Hialuronsav mikrorészecskékbe foglalt hatóanyagokat tartalmazó nyújtott hatóanyagleadású készítmény

Info

Publication number
HUP0000737A2
HUP0000737A2 HU0000737A HUP0000737A HUP0000737A2 HU P0000737 A2 HUP0000737 A2 HU P0000737A2 HU 0000737 A HU0000737 A HU 0000737A HU P0000737 A HUP0000737 A HU P0000737A HU P0000737 A2 HUP0000737 A2 HU P0000737A2
Authority
HU
Hungary
Prior art keywords
microparticles
sustained
hyaluronic acid
release composition
drugs encapsulated
Prior art date
Application number
HU0000737A
Other languages
English (en)
Inventor
Myung Jin Kim
Sun Jin Kim
Oh Ryong Kwon
Original Assignee
Lg Chemical Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=19501732&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HUP0000737(A2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Lg Chemical Limited filed Critical Lg Chemical Limited
Publication of HUP0000737A2 publication Critical patent/HUP0000737A2/hu
Publication of HUP0000737A3 publication Critical patent/HUP0000737A3/hu

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Abstract

Nyújtőtt hatóanyag-leadású készítmény, amely a hialűrőnsavnak vagyszervetlen sójának mikrőrészecskéit és a mikrőrészecskékbe főglaltfehérje vagy peptid hatóanyagőt tartalmaz, ahől a mikrőrészecskékátlagős mérete 0,1 és 40 mm közötti. ŕ
HU0000737A 1997-04-01 1998-03-26 Sustained-release composition of drugs encapsulated in microparticles of hyaluronic acid HUP0000737A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR1019970012046A KR100236771B1 (ko) 1997-04-01 1997-04-01 히아루론산을 이용한 약물의 서방성 미세입자 제형
PCT/KR1998/000062 WO1998043664A1 (en) 1997-04-01 1998-03-26 Sustained-release composition of drugs encapsulated in microparticles of hyaluronic acid

Publications (2)

Publication Number Publication Date
HUP0000737A2 true HUP0000737A2 (hu) 2000-09-28
HUP0000737A3 HUP0000737A3 (en) 2003-05-28

Family

ID=19501732

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0000737A HUP0000737A3 (en) 1997-04-01 1998-03-26 Sustained-release composition of drugs encapsulated in microparticles of hyaluronic acid

Country Status (26)

Country Link
US (3) US20080063727A1 (hu)
EP (1) EP0918535B1 (hu)
JP (1) JP3445283B2 (hu)
KR (1) KR100236771B1 (hu)
CN (1) CN1132625C (hu)
AR (1) AR011208A1 (hu)
AT (1) ATE285245T1 (hu)
AU (1) AU721929B2 (hu)
BG (1) BG64642B1 (hu)
BR (1) BR9804802B1 (hu)
CA (1) CA2256596C (hu)
DE (1) DE69828252T2 (hu)
DK (1) DK0918535T3 (hu)
ES (1) ES2232939T3 (hu)
HK (1) HK1020885A1 (hu)
HU (1) HUP0000737A3 (hu)
ID (1) ID20584A (hu)
IL (1) IL127220A (hu)
MY (1) MY132812A (hu)
NZ (1) NZ333019A (hu)
PL (1) PL195223B1 (hu)
PT (1) PT918535E (hu)
TR (1) TR199802500T1 (hu)
TW (1) TW514532B (hu)
WO (1) WO1998043664A1 (hu)
ZA (1) ZA982533B (hu)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6221854B1 (en) * 1996-03-05 2001-04-24 Orquest, Inc. Method of promoting bone growth with hyaluronic acid and growth factors
KR100236771B1 (ko) * 1997-04-01 2000-02-01 성재갑 히아루론산을 이용한 약물의 서방성 미세입자 제형
JP4234803B2 (ja) * 1997-10-27 2009-03-04 久光製薬株式会社 薬物放出速度が制御された医薬組成物
EP1079801A1 (en) 1998-05-20 2001-03-07 Highchem Company., Ltd. A pharmaceutical formulation for nasal administration
EP1091730A1 (de) * 1998-06-29 2001-04-18 White Spot AG Verwendung von wachstumsfaktoren zur arzneimittelherstellung
NZ512676A (en) 1999-01-13 2003-01-31 Meditech Res Ltd A composition and method for the enhancement of the efficacy of drugs
NZ506975A (en) * 1999-01-18 2004-01-30 Lg Chemical Ltd Lipophilic microparticles containing a protein drug or antigen and formulation comprising same
SE9904121D0 (sv) 1999-11-15 1999-11-15 Gustaf Jederstroem Hydrophobe biomolecular structure
US7785625B2 (en) 2000-01-14 2010-08-31 Lg Life Sciences, Limited Lipophilic-coated microparticle containing a protein drug and formulation comprising same
CA2400172C (en) 2000-02-28 2010-04-20 Genesegues, Inc. Nanocapsule encapsulation system and method
GB0004827D0 (en) * 2000-02-29 2000-04-19 Quadrant Holdings Cambridge Compositions
US9066919B2 (en) * 2000-07-14 2015-06-30 Alchemia Oncology Pty Limited Hyaluronan as a chemo-sensitizer in the treatment of cancer
AUPQ879500A0 (en) 2000-07-14 2000-08-10 Meditech Research Limited Hyaluronan as cytotoxic agent, drug presensitizer and chemo-sensitizer in the treatment of disease
JP4931282B2 (ja) * 2000-10-02 2012-05-16 日本ケミカルリサーチ株式会社 生理活性ペプチド含有粉末
US8637077B2 (en) 2000-12-28 2014-01-28 Takeda Pharmaceutical Company Limited Sustained-release preparation
WO2002085399A1 (en) * 2001-04-20 2002-10-31 Takeda Chemical Industries, Ltd. Peptide-containing preparations
CN1578677A (zh) * 2001-08-27 2005-02-09 美迪泰克研究有限公司 改良的治疗方案
GB0129489D0 (en) * 2001-12-10 2002-01-30 Quadrant Healthcare Uk Ltd Sustained-release compositions
JP4745826B2 (ja) * 2003-11-14 2011-08-10 中外製薬株式会社 架橋多糖微粒子およびその製造方法
WO2005116130A1 (en) * 2004-05-27 2005-12-08 Novozymes Biopolymer A/S A fast dissolving dried hyaluronic acid product
US8143391B2 (en) 2004-09-07 2012-03-27 Chugai Seiyaku Kabushiki Kaisha Process for producing water-soluble hyaluronic acid modification
TW200640492A (en) * 2005-02-21 2006-12-01 Lg Life Sciences Ltd Sustained release composition of protein drug
US8017152B2 (en) 2005-05-27 2011-09-13 Stratosphere Pharma Ab Cores and microcapsules suitable for parenteral administration as well as process for their manufacture
CN103784960A (zh) * 2005-07-27 2014-05-14 阿尔卡米亚肿瘤学股份有限公司 使用乙酰透明质酸的治疗方案
US8319625B2 (en) * 2005-09-01 2012-11-27 Simplexgrinnell Lp Fire alarm textual notification related application
AU2006289651B2 (en) * 2005-09-07 2012-07-26 Alchemia Oncology Pty Limited Therapeutic compositions comprising hyaluronan and therapeutic antibodies as well as methods of treatment
AU2006330833A1 (en) * 2005-12-23 2007-07-05 Altus Pharmaceuticals Inc. Compositions comprising polycation-complexed protein crystals and methods of treatment using them
KR100939983B1 (ko) 2006-10-31 2010-02-03 주식회사 엘지생명과학 히아루론산-소수성 폴리 아미노산 공중합체
FR2931360B1 (fr) * 2008-05-20 2012-05-18 Centre Nat Rech Scient Nanoparticules contenant un peptide, vecteurs les contenant et utilisations pharmaceutiques desdits nanoparticules et vecteurs
KR101183262B1 (ko) 2009-04-22 2012-09-14 (주)알테오젠 체내 지속성을 유지함으로 체내 반감기가 증가된 단백질 또는 펩티드 융합체, 및 이를 이용하여 체내 반감기를 증가시키는 방법
SG181648A1 (en) 2009-12-15 2012-07-30 Ascendis Pharma As Dry growth hormone composition transiently linked to a polymer carrier
US9415012B2 (en) * 2011-06-14 2016-08-16 Ipsen Pharma S.A.S. Sustained-release composition containing peptides as active ingredient
US9399019B2 (en) 2012-05-09 2016-07-26 Evonik Corporation Polymorph compositions, methods of making, and uses thereof
WO2013183948A1 (ko) 2012-06-05 2013-12-12 씨제이제일제당 (주) 고당화된 지속형 인간 성장호르몬 단백질 및 이의 제조방법
WO2015018461A1 (fr) 2013-08-09 2015-02-12 Genbiotech Compositions therapeutiques comprenant d'acide hyaluronique
SG10201902499VA (en) 2014-09-03 2019-04-29 Genesegues Inc Therapeutic nanoparticles and related compositions, methods and systems

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4971782A (en) * 1983-09-14 1990-11-20 Peroxydent Group Periodontal composition and method
US4851521A (en) * 1985-07-08 1989-07-25 Fidia, S.P.A. Esters of hyaluronic acid
JPH0725689B2 (ja) * 1986-10-07 1995-03-22 中外製薬株式会社 顆粒球コロニ−刺激因子を含有する徐放性製剤
JPH02213A (ja) * 1987-10-19 1990-01-05 Taiho Yakuhin Kogyo Kk 生理活性ペプチド持続製剤
JPH01287041A (ja) * 1988-05-13 1989-11-17 Rooman Kogyo:Kk 徐放性製剤
JPH03215430A (ja) * 1990-01-19 1991-09-20 Kita Kiyoshi 関節腔抗凝固剤
US5707644A (en) * 1989-11-04 1998-01-13 Danbiosyst Uk Limited Small particle compositions for intranasal drug delivery
IT1243390B (it) * 1990-11-22 1994-06-10 Vectorpharma Int Composizioni farmaceutiche in forma di particelle atte al rilascio controllato di sostanze farmacologicamente attive e procedimento per la loro preparazione.
JPH04282322A (ja) * 1991-03-08 1992-10-07 Denki Kagaku Kogyo Kk 生物活性ペプチド製剤
JP3283288B2 (ja) * 1991-03-08 2002-05-20 電気化学工業株式会社 生理活性ペプチド製剤
JPH0565231A (ja) * 1991-03-12 1993-03-19 Takeda Chem Ind Ltd エリスロポエチンの持続性製剤
IT1247472B (it) * 1991-05-31 1994-12-17 Fidia Spa Processo per la preparazione di microsfere contenenti componenti biologicamente attivi.
JP3449738B2 (ja) * 1991-07-10 2003-09-22 武田薬品工業株式会社 水溶性組成物
JPH05186364A (ja) * 1991-08-01 1993-07-27 Takeda Chem Ind Ltd 水溶性組成物
EP0535937B2 (en) * 1991-10-01 2008-05-21 Takeda Chemical Industries, Ltd. Prolonged release microparticle preparation and production of the same
JPH08198772A (ja) * 1994-11-25 1996-08-06 Kirin Brewery Co Ltd 顆粒球コロニー刺激因子含有粉末経鼻投与製剤
KR100201352B1 (ko) * 1995-03-16 1999-06-15 성재갑 단일주사 백신 제형
US5641749A (en) * 1995-11-29 1997-06-24 Amgen Inc. Method for treating retinal ganglion cell injury using glial cell line-derived neurothrophic factor (GDNF) protein product
KR100236771B1 (ko) * 1997-04-01 2000-02-01 성재갑 히아루론산을 이용한 약물의 서방성 미세입자 제형
US7276251B2 (en) * 1997-04-01 2007-10-02 Lg Life Sciences, Ltd., Inc. Sustained-release composition of drugs encapsulated in microparticles of hyaluronic acid
JPH09309843A (ja) * 1996-05-21 1997-12-02 Shiseido Co Ltd ヒアルロン酸含有経肺投与用製剤
US6113947A (en) * 1997-06-13 2000-09-05 Genentech, Inc. Controlled release microencapsulated NGF formulation
JP4234803B2 (ja) * 1997-10-27 2009-03-04 久光製薬株式会社 薬物放出速度が制御された医薬組成物
TW577758B (en) * 1997-10-27 2004-03-01 Ssp Co Ltd Intra-articular preparation for the treatment of arthropathy
NZ506975A (en) * 1999-01-18 2004-01-30 Lg Chemical Ltd Lipophilic microparticles containing a protein drug or antigen and formulation comprising same

Also Published As

Publication number Publication date
NZ333019A (en) 1999-08-30
US20110020458A1 (en) 2011-01-27
KR100236771B1 (ko) 2000-02-01
IL127220A0 (en) 1999-09-22
ID20584A (id) 1999-01-21
HK1020885A1 (en) 2000-05-26
BG102969A (en) 1999-09-30
US20130230598A1 (en) 2013-09-05
AU6524198A (en) 1998-10-22
AR011208A1 (es) 2000-08-02
CA2256596C (en) 2005-12-13
TW514532B (en) 2002-12-21
DE69828252T2 (de) 2005-11-10
KR19980075759A (ko) 1998-11-16
BR9804802A (pt) 1999-08-17
MY132812A (en) 2007-10-31
CA2256596A1 (en) 1998-10-08
US20080063727A1 (en) 2008-03-13
WO1998043664A1 (en) 1998-10-08
ZA982533B (en) 1998-09-30
EP0918535B1 (en) 2004-12-22
BR9804802B1 (pt) 2011-04-19
ATE285245T1 (de) 2005-01-15
DE69828252D1 (de) 2005-01-27
BG64642B1 (bg) 2005-10-31
JP3445283B2 (ja) 2003-09-08
EP0918535A1 (en) 1999-06-02
CN1132625C (zh) 2003-12-31
JPH11513047A (ja) 1999-11-09
PL195223B1 (pl) 2007-08-31
ES2232939T3 (es) 2005-06-01
PT918535E (pt) 2005-03-31
IL127220A (en) 2004-12-15
AU721929B2 (en) 2000-07-20
TR199802500T1 (xx) 1999-06-21
PL330230A1 (en) 1999-05-10
DK0918535T3 (da) 2005-04-18
HUP0000737A3 (en) 2003-05-28
CN1222857A (zh) 1999-07-14

Similar Documents

Publication Publication Date Title
HUP0000737A2 (hu) Hialuronsav mikrorészecskékbe foglalt hatóanyagokat tartalmazó nyújtott hatóanyagleadású készítmény
NL300281I2 (nl) Exenatide, desgewenst in de vorm van een farmaceutisch aanvaardbaar zout
NO317747B1 (no) Farmasoytisk preparat samt anvendelse derav
ATE204297T1 (de) Peptidanaloge des lh-rh, ihre verwendungen und die sie enthaltenden pharmazeutischen zusammensetzungen
IL94348A0 (en) Fungicidal agents,comprising substituted amino acid amide derivatives,certain such novel derivatives and their preparation
DK0431877T3 (da) Cimetidinholdige farmaceutiske midler
IS5409A (is) Útskipt karboxamídóþíasól, framleiðsla þeirra og lyfjablöndur sem innihalda þau
MY129566A (en) A hypoallergenic composition containing tolerogenic peptides inducing oral tolerance
DE3875108D1 (de) Physiologisch aktives polypeptid und pharmazeutische komposition.
EP1090912A4 (en) AMINO ACID DERIVATIVES AND MEDICAMENTS CONTAINING THEM AS AN ACTIVE SUBSTANCE
IT1291366B1 (it) Composizione farmaceutica antivirale comprendente acido glicirrizico ed almeno una proteina dotata di attivita' antivirale
CA2388910A1 (en) Antimicrobial activity of the first cationic cluster of human lactoferrin
FR2735132B1 (fr) Medicament polypeptidique modifie, composition et dispositif d'administration par electrotransport le contenant
BG103905A (en) New bpc peptide salts with organoprotective activity, method for their preparation and application in medicine
IT1264546B1 (it) Composizione farmaceutica ad attivita' antiacida in forma di sospensione a base di gel di sucralfato
CA2247998A1 (en) Fragments of cr1 and their use
NO306672B1 (no) N,N-dietyl-8,8-dipropyl-2-azaspiro[4,5]decan-2-propanamindimaleat, farmasöytisk blanding omfattende forbindelsen samt anvendelse derav
PL301900A1 (en) Novel salt of 4-pyrimidinone derivatives, drug and pharmaceutical agent
BG103873A (en) The use of protein-containing microparticles with adsorbed antibody for the preparation of pharmaceutical composition for intranasal administration
BR1100310A (pt) Peptìdeo, composto e composição farmacêutica
DE69834434D1 (de) Verbindung und Arzneizusammensetzung zur Verabreichung von Wirkstoffen
ITRM920677A0 (it) Derivati peptidici, loro preparazione e loro impiego come medicamenti,in particolare antagonisti dell'lh-rh
IL123995A (en) Peptide derivatives, their preparation and pharmaceutical compositions comprising them

Legal Events

Date Code Title Description
FD9A Lapse of provisional protection due to non-payment of fees